Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Active not recruiting 3Recruiting 1

Sponsor Class

NIH 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4

Conditions

Uterine Cervical Neoplasms 4Papillomavirus Infections 4

Interventions

pembrolizumab 7Specimen Handling 6Human Papillomavirus DNA Tests 4Colposcopy 4Paclitaxel 3Magnetic Resonance Spectroscopy 3Fulvestrant 3Cisplatin 3Carboplatin 3palbociclib 2lenvatinib 2Surveys and Questionnaires 2Radiation Dose Hypofractionation 2Nivolumab 2Magnetic Resonance Imaging 2Gemcitabine 2Biopsy 2Bevacizumab 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tisotumab vedotin 1sapanisertib 1ribociclib 1relatlimab 1pertuzumab 1patritumab deruxtecan 1osimertinib 1omipalisib 1liposomal doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Human Papillomavirus DNA Tests × 30 days × Clear all
NCT06498661 2026-05-13

SHIP-A-S01

National Cancer Institute (NCI)

Phase NA Active not recruiting
750 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611540 2026-05-13

LMI-001-A-S03

National Cancer Institute (NCI)

Phase NA Active not recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2026-05-13

LMI-001-A-S02

National Cancer Institute (NCI)

Phase NA Active not recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07281430 2026-05-13

LMI-001-A-S04

National Cancer Institute (NCI)

Phase NA Recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡